eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | neutropenia |
| Comorbidity | C0376545|hematological malignancies |
| Sentences | 8 |
| PubMedID- 22111760 | Bacteria and fungi are the major etiological agents of chemotherapy induced febrile neutropenia in patients with hematological malignancies [1,2]. |
| PubMedID- 20882524 | Micafungin is safe and effective for the empirical antifungal therapy of febrile neutropenia in patients with hematological malignancies. |
| PubMedID- 20662227 | [optimal administration of antimicrobial agents for febrile neutropenia in patients with hematological malignancies]. |
| PubMedID- 23668467 | Antimicrobial agent prescription patterns for chemotherapy-induced febrile neutropenia in patients with hematological malignancies at sultan qaboos university hospital, oman. |
| PubMedID- 20807030 | We investigated mold colonization of air handling units (ahus) of heating, ventilating, and air conditioning (hvac) systems and its effects, including invasive pulmonary mycoses and febrile neutropenia, in patients with hematological malignancies. |
| PubMedID- 25587291 | Methods: a retrospective cohort study was conducted involving patients who had hematological malignancies with profound neutropenia for a minimum of 10 days, and received empirical micafungin or caspofungin for a minimum of five days, between april 2005 and november 2009. |
| PubMedID- 26417163 | Febrile neutropenia in hematological malignancies: clinical and microbiological profile and outcome in high risk patients. |
| PubMedID- 22978686 | Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies. |
Page: 1